Kansas effort to regulate antipsychotics in nursing homes faces opposition ... End of temporary protection for workers sparks panic in caregiving community ... Canadian research points to ibuprofen as early intervention for Alzheimer's
Nursing home founder's death leads to $140K fine.
Skilled nursing leaders criticized a Human Rights Watch report on antipsychotics in February.
Spring Gate Rehabilitation and Healthcare Center in Memphis will pay $500,000 to federal authorities and Tennessee to resolve false claims allegations.
Long-term care insurance payouts increase, and so do woes for policyholders ... New York operators subject of AG investigation back in the SNF market ... Primary care physicians still relying on antipsychotics for dementia symptoms
Reading the disturbing news in McKnight's about the ingestible digital antipsychotic pill that tracks patient data has me all befuddled. I wish I could swallow a pill that would tell me how to feel about it, and what it means for the future of our society and world.
It happens all the time in politics: After dissatisfied voters throw the rascals out, new rascals push back way too hard. Could the same thing happen to the use of antipsychotics in skilled care?
Much of what I know about success (or failure) in life, love and long-term care has been reinforced by lessons learned over years of hiking. As a result, I now take it as a point of professional pride that regardless of the challenge facing our profession, I can always find an analogy to the trail.
A very wise man once told me that when your only tool is a hammer, everything looks like a nail.
Antipsychotics may soon lose their title as the most maligned medications in healthcare if startling headlines, clinical findings and expert opinions are any evidence.
For the treatments to help dementia patients, turn to behavioral health solutions, not antipsychotic drugs. Just like others around the world.
My very adorable, but now elderly puppy has developed a serious problem with wandering. The last time, he was almost hit by a truck. It's rather troubling, to say the least. But long-term care providers may have shown me the way.
Would anyone recommend duplicating something if they didn't feel it was worthy or successful? Of course not. It's this reasoning that should give skilled nursing operators comfort and pride.
It's true that there is danger in not stopping to smell the roses. Yet, in long-term care, it's understandable if you do just that, given how many hassles are tossed your way.
The percent of long-stay nursing home residents receiving antipsychotic medication has decreased 18.8% under a nationwide initiative that started in 2012.
Long-term care providers should take pride in their antipsychotic reduction efforts, and certainly should work hard to meet the new goals announced Friday. But it should not escape their notice that just a day earlier, the White House released an ambitious national plan for addressing antibiotic resistant infections. The plan suggests that a facility's antibiotic stewardship is about to join its antipsychotics rate as a defining feature of quality in the eyes of the government.
Nursing homes face federal False Claims Act charges for allegedly overmedicating residents with antipsychotics, other drugsSeptember 04, 2014
Two California nursing homes routinely overmedicated residents with antipsychotics and other drugs "for the convenience of management," according to federal charges announced Wednesday by the Office of Inspector General.
A Chicago psychiatrist has been stripped of his medical license over charges that he received kickbacks and overprescribed antipsychotic drug clozapine to nursing home residents.
The key to successful medication management is improving processes on multiple fronts so that staff members are more comfortable, confident, efficient and effective.
A husband and wife have pleaded guilty to masterminding a sprawling drug diversion scheme that involved reselling nursing home medications, according to federal and state authorities.
People with dementia are 20% more likely to be rehospitalized, antipsychotic use increases risk, researchers findApril 30, 2014
Seniors are more likely to be rehospitalized within 30 days of discharge if they have dementia, and the risk increases if they are taking an antipsychotic medication, according to recently published research findings. The study also found that discharge to a skilled nursing facility reduced hospital readmission risk when compared to discharge with home health services.
Surveyors will scrutinize dementia care and Minimum Data Set coding in an upcoming pilot program to test more expansive oversight of these areas, the Centers for Medicare & Medicaid Services recently announced.
For reasons that are understandable yet hard to countenance, antipsychotic drugs are widely used in nursing homes. Too often over-used, according to government statistics. But it's beginning to look like new help may arrive — in the form of the iPod.
What do neck abnormalities, dangerous bacteria, a murder-suicide, a defensive nursing home chain, and antipsychotic guidelines have in common? These five developments were voted the most popular news stories appearing on the McKnight's website during 2013.
If you're feeling the suction of the end-of-year vortex grabbing you, you're certainly not alone. Whether it's holiday preparations, work deadlines, challenging weather or a combination of them, you have company. Even if it's just me, you would have company.
Long-term care providers now can access a new interactive program for improving dementia care, developed by a prominent association of medical directors.
The AHCA Quality Initiative goal to reduce antipsychotics use is in sight, the group announced Wednesday. The goal is 15% by the end of this month. The group used federal data in its calculations.
Like many bad habits, the overuse of antipsychotics is not going down without a fight. Still, there are reasons for long-term optimism.
I'm an administrator who's read all of this stuff about overuse of antipsychotics on long-term care residents. I like and trust my director of nursing, medical director and clinical staff — to a degree, that is — but what can I do to REALLY know that we're not overusing this stuff, and would not be liable for some sort of adverse regulatory or court findings?
Pharmaceuticals giant Johnson & Johnson and some subsidiaries will pay more than $2.2 billion to settle claims that they inappropriately promoted antipsychotic drugs for use in nursing homes. The agreement also will settle kickback charges related to the nation's largest long-term care pharmacy, Omnicare.